Doctors sometimes give extra doses of other vaccines, such as the hepatitis B shot, to people with weak immune systems. For transplant patients, powerful immune-suppressing drugs prevent rejection of their new organs but also leave them extremely vulnerable to the COVID-19 virus. This is the reason why they were excluded from the initial testing of the COVID-19 vaccines. Results from the researchThe study tracked 30 transplant patients. However, after an extra shot eight of them, a third developed some virus-fighting antibodies after the extra COVID-19 vaccine shot.

Source: dna June 15, 2021 08:48 UTC